| Amgen (AMGN) |
United States |
$145.144B |
15.66 |
| Bristol Myers Squibb (BMY) |
United States |
$144.465B |
10.02 |
| CSL (CSLLY) |
Australia |
$97.714B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$84.632B |
9.01 |
| Illumina (ILMN) |
United States |
$55.547B |
80.10 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$55.113B |
22.70 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$53.817B |
15.32 |
| BioNTech SE (BNTX) |
Germany |
$48.872B |
35.44 |
| Biogen (BIIB) |
United States |
$41.494B |
9.50 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$37.973B |
14.43 |
| BeiGene (BGNE) |
Cayman Islands |
$27.815B |
0.00 |
| Seagen (SGEN) |
United States |
$24.668B |
42.61 |
| Genmab (GMAB) |
Denmark |
$24.425B |
28.65 |
| Genmab (GNMSF) |
Denmark |
$22.535B |
5.18 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$19.827B |
0.00 |
| CureVac (CVAC) |
Germany |
$19.774B |
0.00 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$19.384B |
24.78 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$18.806B |
45.69 |
| Incyte (INCY) |
United States |
$17.900B |
35.39 |
| Exact Sciences (EXAS) |
United States |
$16.956B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$15.877B |
83.48 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$15.120B |
0.00 |
| Zai Lab (ZLAB) |
China |
$14.151B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$13.960B |
127.32 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$13.191B |
0.00 |
| Guardant Health (GH) |
United States |
$12.315B |
0.00 |
| Novavax (NVAX) |
United States |
$11.892B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$10.690B |
18.98 |
| Repligen (RGEN) |
United States |
$9.615B |
86.70 |
| Exelixis (EXEL) |
United States |
$7.819B |
124.75 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$7.688B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$7.594B |
0.00 |
| AbCellera Biologics (ABCL) |
|
$7.497B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$7.372B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$7.119B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$7.071B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$6.991B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$6.606B |
36.02 |
| Denali Therapeutics (DNLI) |
United States |
$6.250B |
224.22 |
| Sarepta Therapeutics (SRPT) |
United States |
$5.587B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$5.380B |
16.38 |
| Vir Biotechnology (VIR) |
United States |
$5.039B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$4.954B |
17.95 |
| Galapagos (GLPG) |
Belgium |
$4.818B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$4.710B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$4.521B |
0.00 |
| NeoGenomics (NEO) |
United States |
$4.518B |
766.20 |
| Certara (CERT) |
United States |
$4.488B |
0.00 |
| Biohaven Pharmaceutical Holding (BHVN) |
United States |
$4.302B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$4.159B |
0.00 |
| I-Mab (IMAB) |
China |
$4.108B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$4.010B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$3.902B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.840B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$3.634B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.473B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$3.368B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.367B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$3.208B |
6.39 |
| Reata Pharmaceuticals (RETA) |
United States |
$3.068B |
0.00 |
| Berkeley Lights (BLI) |
United States |
$3.018B |
0.00 |
| Arvinas (ARVN) |
United States |
$3.007B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.921B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.883B |
40.74 |
| Insmed (INSM) |
United States |
$2.690B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$2.663B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.498B |
0.00 |
| ALX Oncology Holdings (ALXO) |
United States |
$2.483B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.333B |
0.00 |
| Vericel (VCEL) |
United States |
$2.305B |
621.63 |
| Instil Bio (TIL) |
United States |
$2.233B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$2.122B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.109B |
35.28 |
| Heska (HSKA) |
United States |
$2.051B |
894.45 |
| NGM Biopharmaceuticals (NGM) |
United States |
$2.049B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.049B |
0.00 |
| Ocugen (OCGN) |
United States |
$2.016B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.012B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.992B |
0.00 |
| Kymera Therapeutics (KYMR) |
United States |
$1.980B |
0.00 |
| Seer (SEER) |
|
$1.977B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.958B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.954B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$1.942B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$1.916B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$1.908B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$1.836B |
0.00 |
| Amarin (AMRN) |
Ireland |
$1.806B |
0.00 |
| Morphic Holding (MORF) |
United States |
$1.736B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.732B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.678B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$1.677B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$1.624B |
0.00 |
| PureTech Health (PRTC) |
United States |
$1.624B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$1.549B |
0.00 |
| BioAtla (BCAB) |
United States |
$1.549B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.530B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$1.525B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.481B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.463B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$1.461B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.410B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.397B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.389B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.373B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$1.367B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.315B |
0.00 |
| Precigen (PGEN) |
United States |
$1.288B |
0.00 |
| Alector (ALEC) |
United States |
$1.286B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$1.243B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.235B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$1.210B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.207B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$1.200B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.195B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.167B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.161B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$1.154B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$1.140B |
0.00 |
| Codexis (CDXS) |
United States |
$1.127B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.118B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$1.094B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.082B |
0.00 |
| KaloBios Pharmaceuticals (HGEN) |
United States |
$1.059B |
0.00 |
| MiMedx (MDXG) |
United States |
$1.059B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$1.049B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$1.030B |
0.00 |
| MannKind (MNKD) |
United States |
$1.014B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.992B |
31.33 |
| Scholar Rock Holding (SRRK) |
United States |
$0.973B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.936B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.925B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.922B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.921B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.905B |
0.00 |
| Curis (CRIS) |
United States |
$0.890B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.847B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.838B |
0.00 |
| Epizyme (EPZM) |
United States |
$0.837B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$0.831B |
0.00 |
| Avidity Biosciences (RNA) |
United States |
$0.814B |
0.00 |
| Nkarta (NKTX) |
United States |
$0.806B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.802B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.797B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.782B |
20.83 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$0.761B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.754B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.744B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.741B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.734B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.704B |
0.00 |
| Prometheus Biosciences (RXDX) |
United States |
$0.702B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.683B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.682B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.671B |
0.00 |
| Agenus (AGEN) |
United States |
$0.670B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.642B |
6.47 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.642B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$0.639B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.634B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.621B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.620B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.620B |
53.83 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.598B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.597B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.562B |
0.00 |
| Inhibrx (INBX) |
United States |
$0.560B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.557B |
0.00 |
| ALBIREO PHARMA (ALBO) |
United States |
$0.555B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.553B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.547B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.542B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.529B |
0.00 |
| Adagene (ADAG) |
China |
$0.514B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.509B |
0.00 |
| Verastem (VSTM) |
United States |
$0.506B |
0.00 |
| RAPT THERAPTICS (RAPT) |
United States |
$0.495B |
0.00 |
| Clene (CLNN) |
United States |
$0.492B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.491B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.486B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.461B |
0.00 |
| Neoleukin Therapeutics (NLTX) |
United States |
$0.455B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.443B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.439B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.436B |
0.00 |
| Athenex (ATNX) |
United States |
$0.435B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.429B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.426B |
0.00 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.407B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.407B |
11.23 |
| SESEN BIO, INC (SESN) |
United States |
$0.405B |
0.00 |
| Angion Biomedica (ANGN) |
United States |
$0.398B |
0.00 |
| Geron (GERN) |
United States |
$0.398B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.395B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.394B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.381B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.375B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.373B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.368B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.368B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.366B |
0.00 |
| Opthea (OPT) |
Australia |
$0.365B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.363B |
0.00 |
| Codiak BioSciences (CDAK) |
United States |
$0.362B |
0.00 |
| IBio (IBIO) |
United States |
$0.356B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.355B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.354B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.350B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.345B |
0.00 |
| XOMA (XOMA) |
United States |
$0.345B |
161.16 |
| Oncobiologics (OTLK) |
United States |
$0.344B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.342B |
0.00 |
| Athersys (ATHX) |
United States |
$0.342B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.340B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.336B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.328B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$0.327B |
0.00 |
| SQZ Biotechnologies (SQZ) |
United States |
$0.323B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.320B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.319B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.313B |
12.72 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.310B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.310B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.305B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.302B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.300B |
0.00 |
| Kaleido Biosciences (KLDO) |
|
$0.286B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.286B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.283B |
0.00 |
| Talis Biomedical (TLIS) |
United States |
$0.269B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.267B |
15.39 |
| Arbutus Biopharma (ABUS) |
United States |
$0.255B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.255B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.252B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.250B |
0.00 |
| Trevena (TRVN) |
United States |
$0.249B |
0.00 |
| Cerecor (CERC) |
United States |
$0.242B |
0.00 |
| Chiasma (CHMA) |
United States |
$0.242B |
0.00 |
| OVID THERAPEUTC (OVID) |
United States |
$0.228B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.216B |
0.00 |
| NextCure (NXTC) |
United States |
$0.214B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.203B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.201B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.201B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.194B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.193B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.189B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.187B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.184B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.181B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.170B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.165B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.163B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.163B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.161B |
0.00 |
| VolitionRX (VNRX) |
United States |
$0.160B |
0.00 |
| ObsEva SA (OBSV) |
Switzerland |
$0.159B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.156B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.155B |
3.99 |
| INmune Bio (INMB) |
United States |
$0.154B |
0.00 |
| Exicure (XCUR) |
United States |
$0.153B |
0.00 |
| Erytech Pharma SA (ERYP) |
France |
$0.152B |
0.00 |
| LogicBio Therapeutics (LOGC) |
United States |
$0.150B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.149B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.147B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.141B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.141B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.141B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.139B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.138B |
0.00 |
| ABVC BioPharma (ABVC) |
United States |
$0.135B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.134B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.134B |
0.00 |
| Liminal BioSciences (LMNL) |
Canada |
$0.132B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.125B |
0.00 |
| Evofem Biosciences (EVFM) |
United States |
$0.124B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.123B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.123B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.121B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.120B |
245.50 |
| Eyenovia (EYEN) |
United States |
$0.119B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.119B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.115B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.109B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.108B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.104B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.103B |
0.00 |
| Armata Pharmaceuticals (ARMP) |
United States |
$0.102B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.099B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.098B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.097B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.096B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.094B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.094B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.094B |
0.00 |
| Celsion (CLSN) |
United States |
$0.091B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.090B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.088B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.088B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.085B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.085B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.085B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.081B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.081B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.079B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.078B |
0.00 |
| Adocia (ADOCY) |
France |
$0.077B |
0.00 |
| AIkido Pharma (AIKI) |
United States |
$0.077B |
0.00 |
| Stealth BioTherapeutics (MITO) |
Cayman Islands |
$0.073B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.068B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.065B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.062B |
0.00 |
| CytRx (CYTR) |
United States |
$0.062B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.061B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.061B |
0.00 |
| F-star Therapeutics (FSTX) |
United Kingdom |
$0.061B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.059B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.058B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.058B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.057B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.057B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.056B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.054B |
0.00 |
| ARIDIS PHARMACT (ARDS) |
United States |
$0.053B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.052B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.051B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.049B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.049B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.049B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.048B |
0.00 |
| Brooklyn ImmunoTherapeutics (BTX) |
United States |
$0.048B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.048B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.045B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.043B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.041B |
0.00 |
| Timber Pharmaceuticals (TMBR) |
United States |
$0.040B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.040B |
0.95 |
| Invo BioScience (INVO) |
United States |
$0.039B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.038B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.035B |
0.00 |
| Vyant Bio (VYNT) |
United States |
$0.034B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.034B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.032B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.029B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.028B |
0.00 |
| ThermoGenesis Holdings (THMO) |
United States |
$0.028B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.028B |
0.00 |
| Vallon Pharmaceuticals (VLON) |
United States |
$0.028B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.022B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.015B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$0.000B |
0.00 |
| Immatics (IMTX) |
United States |
$0.000B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |
